CLDX - Historical Earnings Price Analysis
Source: KlickAnalytics
2025-05-04 18:43:27 ET
Celldex Therapeutics, Inc. (CLDX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings.
Opening Gap Moves
Actual Earning Moves
Full story available on KlickAnalytics.com
Celldex Therapeutics Inc.
NASDAQ: CLDX
CLDX Trading
-0.5% G/L:
$29.5709 Last:
247,126 Volume:
$30.29 Open:
CLDX Latest News
February 27, 2026 02:45:00 pm
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAA
February 25, 2026 04:01:00 pm
Celldex Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
CLDX Stock Data
$1,661,236,775
63,525,694
0.16%
57
N/A
Biotechnology & Life Sciences
Healthcare
US
Hampton
